Sodium hyaluronate in cataract surgery. I. Report on the use of Healon in two different types of intracapsular cataract surgery.
Healon has been used in a prospective study as a surgical device for two cataract surgical methods. The study comprised 80 patients divided into two groups. In each group Healon and balanced salt solution (BSS) was randomly applied in two age-matched patient subgroups. The surgical procedures were intracapsular cataract extraction (ICCE) with corneoscleral incision and ICCE with corneal incision. Healon is shown to have a protective effect on the cornea as judged by corneal thickness measurements and by endothelial cell counts. Healon facilitated the surgical procedure in several ways. No side effects, either with regard to intraocular pressure or to postoperative inflammatory reaction have been observed.
D000368:Aged; D002387:Cataract Extraction / Q000379:methods*; D002986:Clinical Trials as Topic; D003315:Cornea / Q000187:drug effects / Q000601:surgery; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects; D007908:Lens, Crystalline / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011446:Prospective Studies; D011897:Random Allocation; D012590:Sclera / Q000601:surgery; D014464:Ultrasonic Therapy
D006820:Hyaluronic Acid